The UKCCMP continues to provide the highest quality evaluations into the effect of the COVID-19 pandemic on cancer patients. Each of these studies have helped us to monitor safeguard and protect those liviing with cancer. We are honoured that our work continues to be at the forefront of the global COVID/Cancer pandemic efforts.
Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID-19: disease control as an important factor relative to recent chemotherapy or anti-CD20 therapy. Booth et al. British Journal of Haematology 2021
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study, Lee et al, Lancet Oncology 2020
COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study, Lee et al, Lancet 2020
The UK Coronavirus Cancer Monitoring Project: protecting patients with cancer in the era of COVID-19, Iris et al, Lancet Oncology 2020.
Crowdsourcing a crisis response for COVID-19 in oncology, Desai et al, Nature Cancer 2020.
Caring for patients with cancer in the COVID-19 era, Haar et al, Nature Medicine 2020
Immune Checkpoint Blockade: Releasing the breaks or a protective barrier to COVID-19 severe acute respiratory syndrome?”, Pickles et al, British Journal of Cancer 2020.
Coronavirus Disease 2019: The pivotal role of UK Clinical Oncology and the UK Coronavirus Cancer Monitoring Project, Best et al, Clinical Oncology 2020.
The Response of the UK Clinical Oncology Community to the COVID-19 Pandemic, Lewis et al, The Royal College of Radiologists 2020.